Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Povidone-iodine

This article was originally published in The Tan Sheet

Executive Summary

Povidone-iodine: 3M submits petition asking FDA to include povidone-iodine acrylate copolymer (.5-1% available iodine) in the OTC health care antiseptic drugs monograph. 3M noted that the health care antiseptics tentative final monograph classified povidone-iodine complex as a Category I (safe and effective) skin preparation ("The Tan Sheet" June 20, 1994, p. 1), and argued that the same factors that determine the safety and efficacy of povidone-iodine complex also cover povidone-iodine acrylate copolymer. 3M said it expects to submit additional data before the end of the comment period...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS083997

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel